• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Hansa Biopharma

Parachute over a mountain in Switzerland
Biotech

Galapagos CEO eyes exit as spinout names leader—Chutes & Ladders

Galapagos CEO eyes exit as spinout names leader. Longtime NIH leader set to retire as chief of staff. Lilly exec jumps to Zealand.
Darren Incorvaia , Zoey Becker Apr 25, 2025 8:30am
Paragliding with Mount Rainier in the background

Cell-focused Sana scoops first CSO—Chutes & Ladders

Aug 30, 2024 8:30am
image of a few paragliders

New federal biotech commission taps 12 members—Chutes & Ladders

Feb 3, 2023 10:20am
On target clinical trial success bullseye score

Hansa touts phase 2 data of one-trick pony transplant therapy

Nov 28, 2022 3:35pm
Redbrick building with Sarepta name and logo

Sarepta bags drug to fully unlock DMD gene therapy opportunity

Jul 2, 2020 8:20am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings